OKYO Pharma
OKYO
6 hedge funds and large institutions have $1.02M invested in OKYO Pharma in 2024 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
0.09% less ownership
Funds ownership: 3.04% → 2.95% (-0.09%)
14% less funds holding
Funds holding: 7 → 6 (-1)
16% less capital invested
Capital invested by funds: $1.21M → $1.02M (-$188K)
50% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 2
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$17.2K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HSBC Holdings
London,
United Kingdom
|
-$20.3K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$13.6K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$1.59K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Barclays
London,
United Kingdom
| $980K | – | – | – |
|
|
2
Citadel Advisors
Miami,
Florida
| $15.3K | +$17.2K | +14,876 | New |
|
3
Cerity Partners
New York
| $13.1K | – | – | – |
|
4
Geode Capital Management
Boston,
Massachusetts
| $12.5K | – | – | – |
|
|
5
UBS Group
Zurich,
Switzerland
| $536 | -$1.59K | -1,379 | -72% |
|
|
CA
6
Continuum Advisory
Eagle,
Idaho
| $53 | – | – | – |
|
|
7
HSBC Holdings
London,
United Kingdom
| – | -$20.3K | -11,933 | Closed |
|
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$13.6K | -11,123 | Closed |
|
OKYO Hedge Fund Activity: Q3 2024 in Review
6 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in OKYO Pharma (OKYO) for Q3 2024, worth a combined $1.02M — down 16% from $1.21M a quarter earlier.
Sellers outnumbered buyers: 2 funds closed out of OKYO and 1 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $17.2K. The largest seller was HSBC Holdings, exiting entirely with an estimated $20.3K sold.
- 6 institutional investors held OKYO Pharma (OKYO) as of Q3 2024, down from 7 in Q2 2024.
- Funds reported $1.02M of OKYO Pharma stock for Q3 2024, down 16% quarter-over-quarter.
- 1 fund opened new OKYO Pharma positions in Q3 2024 and 2 closed out, a net change of -1 holder.
- The largest OKYO Pharma buyer in Q3 2024 was Citadel Advisors, an estimated $17.2K added.
- The largest OKYO Pharma seller in Q3 2024 was HSBC Holdings, an estimated $20.3K sold.
Based on aggregated 13F filings for Q3 2024.